Stress Management Industry Expands During COVID-19 Woes—But Not Pills
Industry Boosted by Global Uncertainty and Fear
June 18, 2020
The global market for stress management treatments should reach $20.6 billion by 2024, growing 3.7% annually, according to the latest report by BCC Research, Stress Management Industry: Global Trends.
Trends that started long before the present pandemic in the stress management market—stalling growth in antidepressant medications; diminished stigma surrounding mental health; accelerated growth in non-pharmaceutical treatments and devices—are surging due to worldwide uncertainty and fear.
Report Highlights
- The device and non-pharmaceutical segment of the stress management treatments market—while still dwarfed by pharmaceuticals—will grow at more than triple the CAGR of the traditional medicine segment, at 9.3% annually.
- Treatments such as transcranial stimulation and electroconvulsive therapy, as well as cognitive therapy interventions, can be remarkably effective for large populations of patients.
- The prime market to aim for now is the moderately impaired, well-informed patient population seeking non-pharmacologic interventions based on sound therapy, and increasingly, delivered via mobile and web platforms and devices.
Read the full report here: https://www.bccresearch.com/market-research/healthcare/stress-management-industry-report.html
“The significance of innovative therapies will attract research institutes, government and private organizations, major hospitals and investment companies to explore the stress management market,” write BCC analysts. “The presence of global giants and emerging players coupled with potential startups paving their way in the stress management market keep the market in trend.”
About BCC Research
BCC Research publishes market research reports that provide organizations with intelligence to drive smart business decisions. By partnering with industry experts worldwide, BCC Research provides unbiased measurements and assessments of global markets covering current and emerging industrial and technology sectors. For more information about BCC Research, visit bccresearch.com.
Stress Management Industry: Global Trends( HLC256A )
Publish Date: Feb 2020
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Health Maintenance
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis
- Healthcare Predictive Analytics Market to Grow at 24.7% CAGR Through 2030
- mHealth Technologies Market Poised for 17.1% CAGR Growth Through 2030
Reports from Health Maintenance
- State of the Life Sciences Industry - 2026 First Quarter Review
- Noninvasive Cancer Diagnostics: Technologies and Global Markets
- Infusion Pumps and Devices: Technologies and Global Markets
- Technologies for Long-Term Care and Home Healthcare: Global Markets
- 3D Protein Structure Analysis: Global Markets
Recent News
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development